Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.34 |
| ▸ | HRH1 | P35367 | 4/20 | 0.33 |
| ▸ | HTR2A | P28223 | 3/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140408 | 0.85 | CYP2D6 (0.37) | HRH1HTR2ACYP2D6KCNH2 | |
| SCHEMBL27593435 | 0.83 | HRH1 (0.50) | GRIN1GRIN2AHRH1HTR2ASIGMAR1 | |
| SCHEMBL8357721 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL3684109 | 0.82 | HRH1 (0.50) | HRH1HTR2A | |
| SCHEMBL8352391 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL25273765 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL22471827 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL22471836 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL22471869 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 | |
| SCHEMBL8351977 | 0.82 | NAAA (0.43) | HTR2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035308-A1 | METHODS OF MAKING 6-HYDROXYHEXANOPHENONE AND 5-BENZOYLPENTANOIC ACID AND MONO OR DIESTERS THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035308-A1 | METHODS OF MAKING 6-HYDROXYHEXANOPHENONE AND 5-BENZOYLPENTANOIC ACID AND MONO OR DIESTERS THEREOF | HAAO, OXER1, CYP26B1 | GRIN1 4427/4885GRIN2A 4060/4885HRH1 1239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.